title: Cutaneous adverse reaction of mogamulizumab, an anti-CC chemokine receptor 4 monoclonal antibody: Shared histopathological features with thymoma-associated multi-organ autoimmunity.
authors.affiliation: Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
authors.forename: Kyoko
authors.identifier: http://orcid.org/0000-0003-3135-9254
authors.initials: K
authors.lastname: Kanno
authors.affiliation: Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
authors.forename: Masaru
authors.initials: M
authors.lastname: Honma
authors.affiliation: Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
authors.forename: Akemi
authors.initials: A
authors.lastname: Ishida-Yamamoto
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015551:Autoimmunity / Q000187:drug effects*; D003875:Drug Eruptions / Q000276:immunology*; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell; D054398:Receptors, CCR4 / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D013945:Thymoma / Q000276:immunology; D013953:Thymus Neoplasms / Q000175:diagnosis / Q000276:immunology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C515354:CCR4 protein, human; D054398:Receptors, CCR4; C549035:mogamulizumab